<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>HIV/AIDS News &#38; Information &#187; Drugs</title>
	<atom:link href="http://www.hiv-infected.com/category/drugs/feed" rel="self" type="application/rss+xml" />
	<link>http://www.hiv-infected.com</link>
	<description></description>
	<lastBuildDate>Fri, 27 Jan 2012 04:24:36 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1</generator>
		<item>
		<title>Physiologic Effects and Side Effects of Prostaglandin E1: DISCUSSION part 2</title>
		<link>http://www.hiv-infected.com/2011/05/physiologic-effects-and-side-effects-of-prostaglandin-e1-discussion-part-2.html</link>
		<comments>http://www.hiv-infected.com/2011/05/physiologic-effects-and-side-effects-of-prostaglandin-e1-discussion-part-2.html#comments</comments>
		<pubDate>Sun, 15 May 2011 12:44:44 +0000</pubDate>
		<dc:creator>Steve</dc:creator>
				<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Distress Syndrome]]></category>
		<category><![CDATA[Physiologic Effects]]></category>
		<category><![CDATA[Prostaglandin E1]]></category>

		<guid isPermaLink="false">http://www.hiv-infected.com/?p=2469</guid>
		<description><![CDATA[Supraventricular dysrhythmias (atrial fibrillation and paroxysmal supraventricular tachycardia) were the most common adverse effects, occurring in 24 percent (4/17) of PGE,-treated patients, and were associated with hypotension in two cases and cardiac arrest in one (Table 4). Prostaglandin E, may have caused supraventricular dysrhythmias in patients par­ticularly prone to dysrhythmias. All patients who developed supraventricular [...]]]></description>
		<wfw:commentRss>http://www.hiv-infected.com/2011/05/physiologic-effects-and-side-effects-of-prostaglandin-e1-discussion-part-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Physiologic Effects and Side Effects of Prostaglandin E1: DISCUSSION</title>
		<link>http://www.hiv-infected.com/2011/05/physiologic-effects-and-side-effects-of-prostaglandin-e1-discussion.html</link>
		<comments>http://www.hiv-infected.com/2011/05/physiologic-effects-and-side-effects-of-prostaglandin-e1-discussion.html#comments</comments>
		<pubDate>Sun, 15 May 2011 04:44:18 +0000</pubDate>
		<dc:creator>Steve</dc:creator>
				<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Distress Syndrome]]></category>
		<category><![CDATA[Physiologic Effects]]></category>
		<category><![CDATA[Prostaglandin E1]]></category>

		<guid isPermaLink="false">http://www.hiv-infected.com/?p=2468</guid>
		<description><![CDATA[Infusion of PGE, in patients who had ARDS de­creased the SVRI and extraction ratio of oxygen and increased total and polymorphonuclear leukocyte con­centrations, indicating significant systemic vasodila­tion and possibly reduced intrapulmonary leukocyte sequestration, respectively; however, PGE, did not change oxygen delivery and oxygen consumption, and there were no differences in oxygen delivery and oxygen consumption [...]]]></description>
		<wfw:commentRss>http://www.hiv-infected.com/2011/05/physiologic-effects-and-side-effects-of-prostaglandin-e1-discussion.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Physiologic Effects and Side Effects of Prostaglandin E1: RESULTS part 2</title>
		<link>http://www.hiv-infected.com/2011/05/physiologic-effects-and-side-effects-of-prostaglandin-e1-results-part-2.html</link>
		<comments>http://www.hiv-infected.com/2011/05/physiologic-effects-and-side-effects-of-prostaglandin-e1-results-part-2.html#comments</comments>
		<pubDate>Sat, 14 May 2011 03:43:51 +0000</pubDate>
		<dc:creator>Steve</dc:creator>
				<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Distress Syndrome]]></category>
		<category><![CDATA[Physiologic Effects]]></category>
		<category><![CDATA[Prostaglandin E1]]></category>

		<guid isPermaLink="false">http://www.hiv-infected.com/?p=2467</guid>
		<description><![CDATA[Significant thrombocytopenia occurred in three patients (platelet concentrations of 32, 44, and 24 x 10/ml). These patients were receiving medica­tions and had illnesses (sepsis; disseminated intravas­cular coagulation) associated with thrombocytopenia. After cessation of PGE,, platelet concentrations rose to 117,189, and 113 x KF/ml and continued to increase in one patient (case 6) when PGE, was [...]]]></description>
		<wfw:commentRss>http://www.hiv-infected.com/2011/05/physiologic-effects-and-side-effects-of-prostaglandin-e1-results-part-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Physiologic Effects and Side Effects of Prostaglandin E1: RESULTS</title>
		<link>http://www.hiv-infected.com/2011/05/physiologic-effects-and-side-effects-of-prostaglandin-e1-results.html</link>
		<comments>http://www.hiv-infected.com/2011/05/physiologic-effects-and-side-effects-of-prostaglandin-e1-results.html#comments</comments>
		<pubDate>Thu, 12 May 2011 14:41:36 +0000</pubDate>
		<dc:creator>Steve</dc:creator>
				<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Distress Syndrome]]></category>
		<category><![CDATA[Physiologic Effects]]></category>
		<category><![CDATA[Prostaglandin E1]]></category>

		<guid isPermaLink="false">http://www.hiv-infected.com/?p=2466</guid>
		<description><![CDATA[The clinical characteristics of the PGE,-treated and control patients are presented in Table 1. There were no differences in the age, sex, APACHE II or ARDS scores, or cause of ARDS between PGE ^treated and control patients. The most common causes of ARDS in PGE,-treated and control patients were sepsis, aspiration syndrome, and multiple trauma. [...]]]></description>
		<wfw:commentRss>http://www.hiv-infected.com/2011/05/physiologic-effects-and-side-effects-of-prostaglandin-e1-results.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Physiologic Effects and Side Effects of Prostaglandin E1: MATERIALS AND METHODS part 2</title>
		<link>http://www.hiv-infected.com/2011/05/physiologic-effects-and-side-effects-of-prostaglandin-e1-materials-and-methods-part-2.html</link>
		<comments>http://www.hiv-infected.com/2011/05/physiologic-effects-and-side-effects-of-prostaglandin-e1-materials-and-methods-part-2.html#comments</comments>
		<pubDate>Wed, 11 May 2011 19:49:35 +0000</pubDate>
		<dc:creator>Steve</dc:creator>
				<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Distress Syndrome]]></category>
		<category><![CDATA[Physiologic Effects]]></category>
		<category><![CDATA[Prostaglandin E1]]></category>

		<guid isPermaLink="false">http://www.hiv-infected.com/?p=2465</guid>
		<description><![CDATA[Measurements Right atrial, pulmonary arterial, and pulmonary arterial occlusion pressures were measured at the end of expiration referenced to atmospheric pressure using flow-directed pulmonary arterial cath­eters (Gould Inc), transducers (Gould Inc), and bedside monitors. Cardiac output was measured in triplicate using the thermodilution technique (Gould Inc), with room-temperature 5 percent dextrose in water. Systemic arterial [...]]]></description>
		<wfw:commentRss>http://www.hiv-infected.com/2011/05/physiologic-effects-and-side-effects-of-prostaglandin-e1-materials-and-methods-part-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

